FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

David Scott

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Occupations

Rheumatology

Anatomy

Joints

Procedures

Activities & Behaviors

Questionnaires

Co-author Network

Publications

TOP 3
Abdul Khan; David Scott
Rituximab after methotrexate failure in rheumatoid arthritis: evaluation of the SERENE trial.
Samantha Schröder; Franca Fraternali; Xueping Quan; David Scott; Feng Qian; Mark Pfuhl
When a module is not a domain: the case of the REJ module and the redefinition of the architecture of polycystin-1.
Suzanne Lloyd; Sylwia Bujkiewicz; Allan Wailoo; Alex J Sutton; David Scott
The effectiveness of anti-TNF-alpha therapies when used sequentially in rheumatoid arthritis patients: a systematic review and meta-analysis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of David Scott (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Abdul Khan; David Scott
Rituximab after methotrexate failure in rheumatoid arthritis: evaluation of the SERENE trial.
Expert opinion on biological therapy 2011;11(11):1515-8.
2011: Samantha Schröder; Franca Fraternali; Xueping Quan; David Scott; Feng Qian; Mark Pfuhl
When a module is not a domain: the case of the REJ module and the redefinition of the architecture of polycystin-1.
The Biochemical journal 2011;435(3):651-60.
2010: Suzanne Lloyd; Sylwia Bujkiewicz; Allan Wailoo; Alex J Sutton; David Scott
The effectiveness of anti-TNF-alpha therapies when used sequentially in rheumatoid arthritis patients: a systematic review and meta-analysis.
Rheumatology (Oxford, England) 2010;49(12):2313-21.
2010: David Scott
Osteoarthritis of the hip.
American family physician 2010;81(4):444.
2010: Margaret H Y Ma; Gabrielle Kingsley; David Scott
A systematic comparison of combination DMARD therapy and tumour necrosis inhibitor therapy with methotrexate in patients with early rheumatoid arthritis.
Rheumatology (Oxford, England) 2010;49(1):91-8.
2009: Helen Graves; David Scott; Heidi Lempp; John Weinman
Illness beliefs predict disability in rheumatoid arthritis.
Journal of psychosomatic research 2009;67(5):417-23.
2009: Heidi Lempp; Graham Thornicroft; Morven Nesmith Leese; Naomi Fearns; Helen Graves; B Khoshaba; Antonio Lasalvia; David Scott; Michele Tansella
Implications of long-term conditions for both mental and physical health: comparison of rheumatoid arthritis and schizophrenia.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2009;18(6):699-707.
2009: David Scott; Andrew Cope
New tumour necrosis factor inhibitors for rheumatoid arthritis: are there benefits from extending choice?
Annals of the rheumatic diseases 2009;68(6):767-9.
2009: David Scott
What have we learnt about the development and progression of early RA from RCTs?
Best practice & research. Clinical rheumatology 2009;23(1):13-24.
2009: David Scott; Sophia Steer
NICE guidelines on anti-tumor necrosis factor therapy for RA.
Nature clinical practice. Rheumatology 2009;5(1):16-7.
2008: Paul A Scott; Gabrielle H Kingsley; David Scott
Non-steroidal anti-inflammatory drugs and cardiac failure: meta-analyses of observational studies and randomised controlled trials.
European journal of heart failure 2008;10(11):1102-7.
2008: V Ravindran; David Scott; E H S Choy
A systematic review and meta-analysis of efficacy and toxicity of disease modifying anti-rheumatic drugs and biological agents for psoriatic arthritis.
Annals of the rheumatic diseases 2008;67(6):855-9.
2008: Pradip Nandi; Gabrielle H Kingsley; David Scott
Disease-modifying antirheumatic drugs other than methotrexate in rheumatoid arthritis and seronegative arthritis.
Current opinion in rheumatology 2008;20(3):251-6.
2008: E H S Choy; C M Smith; V Farewell; D Walker; A Hassell; L Chau; David Scott
Factorial randomised controlled trial of glucocorticoids and combination disease modifying drugs in early rheumatoid arthritis.
Annals of the rheumatic diseases 2008;67(5):656-63.
2008: David Scott; Anna Kowalczyk
Osteoarthritis of the knee.
American family physician 2008;77(8):1149-50.
2008: David Scott; Deborah Symmons
The role of specialists in managing established rheumatoid arthritis.
Rheumatology (Oxford, England) 2008;47(3):237-8.
2008: E H S Choy; B Khoshaba; Derek Cooper; Alex MacGregor; David Scott
Development and validation of a patient-based disease activity score in rheumatoid arthritis that can be used in clinical trials and routine practice.
Arthritis and rheumatism 2008;59(2):192-9.
2008: Vinod Ravindran; May-Ai Seah; David A Elias; Ernest H Choy; David Scott; Patrick A Gordon
Clinical and radiological features of rheumatoid arthritis in British black Africans.
Clinical rheumatology 2008;27(1):97-100.
2007: David Scott; B Khoshaba; E H S Choy; Gabrielle Kingsley
Limited correlation between the Health Assessment Questionnaire (HAQ) and EuroQol in rheumatoid arthritis: questionable validity of deriving quality adjusted life years from HAQ.
Annals of the rheumatic diseases 2007;66(11):1534-7.
2007: David Scott; Sophia Steer
The course of established rheumatoid arthritis.
Best practice & research. Clinical rheumatology 2007;21(5):943-67.
2007: David Scott
Preface. Established rheumatoid arthritis.
Best practice & research. Clinical rheumatology 2007;21(5):805.
2007: P A Scott; Gabrielle Kingsley; C M Smith; E H S Choy; David Scott
Non-steroidal anti-inflammatory drugs and myocardial infarctions: comparative systematic review of evidence from observational studies and randomised controlled trials.
Annals of the rheumatic diseases 2007;66(10):1296-304.
2007: Laurence Maiden; Bjarni Thjodleifsson; Anna Seigal; Ingvar Iain Bjarnason; David Scott; Sigurbjorn Birgisson; Ingvar Bjarnason
Long-term effects of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 selective agents on the small bowel: a cross-sectional capsule enteroscopy study.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2007;5(9):1040-5.
2007: MC Greenwood; J Rathi; Alan J Hakim; David Scott; DV Doyle
Regression to the mean using the disease activity score in eligibility and response criteria for prescribing TNF-alpha inhibitors in adults with rheumatoid arthritis.
Rheumatology (Oxford, England) 2007;46(7):1165-7.
2007: Yuen-Li Chung; Helene Alexanderson; Nicoló Pipitone; Catherine Morrison; Maryam Dastmalchi; Christina Ståhl-Hallengren; Selwyn Richards; E Louise Thomas; Gavin Hamilton; Jimmy D Bell; Ingrid E Lundberg; David Scott
Creatine supplements in patients with idiopathic inflammatory myopathies who are clinically weak after conventional pharmacologic treatment: Six-month, double-blind, randomized, placebo-controlled trial.
Arthritis and rheumatism 2007;57(4):694-702.
2007: Mark Harrison; Andrew B Hassell; Peter T Dawes; David Scott; SM Knight; M J Davis; Diarmuid Mulherin; Deborah Symmons
The overall status in rheumatoid arthritis (OSRA) measure--further evidence to support its use in clinical practice.
Rheumatology (Oxford, England) 2007;46(5):849-55.
2007: linda davies; Emily Anne Fargher; Karen J Tricker; Peter Dawes; David Scott; Deborah Symmons
Is shared care with annual hospital review better value for money than predominantly hospital-based care in patients with established stable rheumatoid arthritis?
Annals of the rheumatic diseases 2007;66(5):658-63.
2007: K A Vincent; A J Carr; J Walburn; David Scott; M R Rose
Construction and validation of a quality of life questionnaire for neuromuscular disease (INQoL).
Neurology 2007;68(13):1051-7.
2007: David Scott; Anna Kowalczyk
Osteoarthritis of the knee.
Clinical evidence 2007;2007():.
2007: David Scott
Early rheumatoid arthritis.
British medical bulletin 2007;81-82():97-114.
2006: Heidi Lempp; David Scott; Gabrielle Kingsley
Patients' views on the quality of health care for rheumatoid arthritis.
Rheumatology (Oxford, England) 2006;45(12):1522-8.
2006: David Scott; G H Kingsley
Tumor necrosis factor inhibitors for rheumatoid arthritis.
The New England journal of medicine 2006;355(7):704-12.
2006: AG Witney; Gareth J Treharne; M Tavakoli; Antonia C Lyons; K Vincent; David Scott; George D Kitas
The relationship of medical, demographic and psychosocial factors to direct and indirect health utility instruments in rheumatoid arthritis.
Rheumatology (Oxford, England) 2006;45(8):975-81.
2006: Louise Pollard; E H S Choy; J Gonzalez; B Khoshaba; David Scott
Fatigue in rheumatoid arthritis reflects pain, not disease activity.
Rheumatology (Oxford, England) 2006;45(7):885-9.
2006: Heidi Lempp; David Scott; Gabrielle Kingsley
The personal impact of rheumatoid arthritis on patients' identity: a qualitative study.
Chronic illness 2006;2(2):109-20.
2006: H L Mitchell; A J Carr; David Scott
The management of knee pain in primary care: factors associated with consulting the GP and referrals to secondary care.
Rheumatology (Oxford, England) 2006;45(6):771-6.
2006: David Scott
Rheumatoid arthritis: acute presentations and urgent complications.
British journal of hospital medicine (London, England : 2005) 2006;67(5):235-9.
2006: Deborah Symmons; Karen J Tricker; Mark Harrison; C Roberts; M Davis; Peter Dawes; Andrew B Hassell; S Knight; Diarmuid Mulherin; David Scott
Patients with stable long-standing rheumatoid arthritis continue to deteriorate despite intensified treatment with traditional disease modifying anti-rheumatic drugs--results of the British Rheumatoid Outcome Study Group randomized controlled clinical trial.
Rheumatology (Oxford, England) 2006;45(5):558-65.
2006: I Pande; David Scott; T W O'Neill; C Pritchard; A D Woolf; M J Davis
Quality of life, morbidity, and mortality after low trauma hip fracture in men.
Annals of the rheumatic diseases 2006;65(1):87-92.
2005: Jiri Chard; Stefan Lohmander; Claire Smith; David Scott
Osteoarthritis of the knee.
Clinical evidence 2005;(14):1506-22.
2005: Mark Harrison; Karen J Tricker; linda davies; Andrew B Hassell; Peter Dawes; David Scott; Susan Knight; Martin Davis; Diarmuid Mulherin; Deborah Symmons
The relationship between social deprivation, disease outcome measures, and response to treatment in patients with stable, long-standing rheumatoid arthritis.
The Journal of rheumatology 2005;32(12):2330-6.
2005: E H S Choy; C Smith; C J Doré; David Scott
A meta-analysis of the efficacy and toxicity of combining disease-modifying anti-rheumatic drugs in rheumatoid arthritis based on patient withdrawal.
Rheumatology (Oxford, England) 2005;44(11):1414-21.
2005: Louise Pollard; E H S Choy; David Scott
The consequences of rheumatoid arthritis: quality of life measures in the individual patient.
Clinical and experimental rheumatology 2005;23(5 Suppl 39):S43-52.
2005: Deborah Symmons; Karen J Tricker; C Roberts; linda davies; Peter Dawes; David Scott
The British Rheumatoid Outcome Study Group (BROSG) randomised controlled trial to compare the effectiveness and cost-effectiveness of aggressive versus symptomatic therapy in established rheumatoid arthritis.
Health technology assessment (Winchester, England) 2005;9(34):iii-iv, ix-x, 1-78.
2005: E H S Choy; Gabrielle Kingsley; B Khoshaba; Nicolò Pipitone; David Scott
A two year randomised controlled trial of intramuscular depot steroids in patients with established rheumatoid arthritis who have shown an incomplete response to disease modifying antirheumatic drugs.
Annals of the rheumatic diseases 2005;64(9):1288-93.
2005: S J Farrow; G H Kingsley; David Scott
Interventions for foot disease in rheumatoid arthritis: a systematic review.
Arthritis and rheumatism 2005;53(4):593-602.
2005: Y-L Chung; Lisa G Rider; J D Bell; Ronald M Summers; Lawrence S Zemel; Robert M Rennebohm; Murray H Passo; J Hicks; Frederick W Miller; David Scott
Muscle metabolites, detected in urine by proton spectroscopy, correlate with disease damage in juvenile idiopathic inflammatory myopathies.
Arthritis and rheumatism 2005;53(4):565-70.
2005: Gabrielle Kingsley; B Khoshaba; C M Smith; E H S Choy; David Scott
Are clinical trials in rheumatoid arthritis generalizable to routine practice? A re-evaluation of trial entry criteria.
Rheumatology (Oxford, England) 2005;44(5):629-32.
2005: Vibeke Strand; David Scott; Paul Emery; Joachim R Kalden; Josef S Smolen; Grant W Cannon; Peter Tugwell; Bruce Crawford
Physical function and health related quality of life: analysis of 2-year data from randomized, controlled studies of leflunomide, sulfasalazine, or methotrexate in patients with active rheumatoid arthritis.
The Journal of rheumatology 2005;32(4):590-601.
2005: P Maddison; P Kiely; B Kirkham; T Lawson; Robert J Moots; D Proudfoot; R Reece; David Scott; R Sword; A Taggart; C Thwaites; E Williams
Leflunomide in rheumatoid arthritis: recommendations through a process of consensus.
Rheumatology (Oxford, England) 2005;44(3):280-6.
2005: David Scott; Claire Smith; Gabrielle Kingsley
What are the consequences of early rheumatoid arthritis for the individual?
Best practice & research. Clinical rheumatology 2005;19(1):117-36.
2005: David Scott
Etanercept in arthritis.
International journal of clinical practice 2005;59(1):114-8.
2004: David Scott; Gabrielle Kingsley
Use of imaging to assess patients with muscle disease.
Current opinion in rheumatology 2004;16(6):678-83.
2004: David Scott
Managing fibromyalgia.
The Practitioner 2004;248(1664):784, 786-8, 790 passim.
2004: Désirée van der Heijde; J Kalden; David Scott; Josef Smolen; Vibeke Strand
Long term evaluation of radiographic disease progression in a subset of patients with rheumatoid arthritis treated with leflunomide beyond 2 years.
Annals of the rheumatic diseases 2004;63(6):737-9.
2004: Vibeke Strand; S Cohen; B Crawford; Josef S Smolen; David Scott
Patient-reported outcomes better discriminate active treatment from placebo in randomized controlled trials in rheumatoid arthritis.
Rheumatology (Oxford, England) 2004;43(5):640-7.
2004: David Scott
Interstitial lung disease and disease modifying anti-rheumatic drugs.
Lancet 2004;363(9416):1239-40.
2004: David Scott
Radiological progression in established rheumatoid arthritis.
The Journal of rheumatology. Supplement 2004;69():55-65.
2004: David Scott; Gabrielle Kingsley
Translating research into practice: acetaminophen in osteoarthritis revisited.
The Journal of rheumatology 2004;31(2):199-202.
2004: David Scott
Pursuit of optimal outcomes in rheumatoid arthritis.
PharmacoEconomics 2004;22(2 Suppl 1):13-26.
2004: David A Isenberg; E Allen; Vernon T Farewell; Michael R Ehrenstein; Michael G Hanna; Ingrid E Lundberg; Chester V Oddis; Clarissa Pilkington; Paul H Plotz; David Scott; Jiri Vencovsky; R Cooper; Lisa G Rider; F Miller
International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease.
Rheumatology (Oxford, England) 2004;43(1):49-54.
2003: David Scott; Claire Smith; Stefan Lohmander; Jiri Chard
Osteoarthritis.
Clinical evidence 2003;(10):1402-30.
2003: Nicolò Pipitone; Gabrielle Kingsley; Antonio Manzo; David Scott; Costantino Pitzalis
Current concepts and new developments in the treatment of psoriatic arthritis.
Rheumatology (Oxford, England) 2003;42(10):1138-48.
2003: David Scott; C Smith; G Kingsley
Joint damage and disability in rheumatoid arthritis: an updated systematic review.
Clinical and experimental rheumatology 2003;21(5 Suppl 31):S20-7.
2003: Atulya A Deodhar; J Brabyn; I Pande; David Scott; A D Woolf
Hand bone densitometry in rheumatoid arthritis, a five year longitudinal study: an outcome measure and a prognostic marker.
Annals of the rheumatic diseases 2003;62(8):767-70.
2003: David Scott; C Antoni; E H Choy; P C L M Van Riel
Joint counts in routine practice.
Rheumatology (Oxford, England) 2003;42(8):919-23.
2003: David Scott
Genotypes and phenotypes: should genetic markers and clinical predictors drive initial treatment decisions in rheumatic diseases?
Current opinion in rheumatology 2003;15(3):213-8.
2003: Y-L Chung; W S Wassif; J D Bell; M Hurley; David Scott
Urinary levels of creatine and other metabolites in the assessment of polymyositis and dermatomyositis.
Rheumatology (Oxford, England) 2003;42(2):298-303.
2003: Josef Zacher; D Feldman; R Gerli; David Scott; S-M Hou; D Uebelhart; I W Rodger; Z E Ozturk
A comparison of the therapeutic efficacy and tolerability of etoricoxib and diclofenac in patients with osteoarthritis.
Current medical research and opinion 2003;19(8):725-36.
2002: Jiri Chard; Stefan Lohmander; Claire Smith; David Scott
Osteoarthritis.
Clinical evidence 2002;(8):1212-37.
2002: David Scott; Vibeke Strand
The effects of disease-modifying anti-rheumatic drugs on the Health Assessment Questionnaire score. Lessons from the leflunomide clinical trials database.
Rheumatology (Oxford, England) 2002;41(8):899-909.
2002: Selwyn C M Richards; David Scott
Prescribed exercise in people with fibromyalgia: parallel group randomised controlled trial.
BMJ (Clinical research ed.) 2002;325(7357):185.
2002: E H S Choy; David Scott; Gabrielle Kingsley; P Williams; J Wojtulewski; G Papasavvas; E Henderson; D Macfarlane; C Erhardt; A Young; M J Plant; Gabriel S Panayi
Treating rheumatoid arthritis early with disease modifying drugs reduces joint damage: a randomised double blind trial of sulphasalazine vs diclofenac sodium.
Clinical and experimental rheumatology 2002;20(3):351-8.
2002: David Scott
Advances in the medical management of rheumatoid arthritis.
Hospital medicine (London, England : 1998) 2002;63(5):294-7.
2002: Lindsay M Bearne; David Scott; Michael V Hurley
Exercise can reverse quadriceps sensorimotor dysfunction that is associated with rheumatoid arthritis without exacerbating disease activity.
Rheumatology (Oxford, England) 2002;41(2):157-66.
2002: David Scott
The diagnosis and prognosis of early arthritis: rationale for new prognostic criteria.
Arthritis and rheumatism 2002;46(2):286-90.
2001: Frederick W Miller; Lisa G Rider; Y L Chung; R Cooper; K Danko; Vernon T Farewell; I Lundberg; C Morrison; L Oakley; I Oakley; Clarissa Pilkington; Jiri Vencovsky; K Vincent; David Scott; David A Isenberg
Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathies.
Rheumatology (Oxford, England) 2001;40(11):1262-73.
2001: David Scott; Josef S Smolen; Joachim R Kalden; L B van de Putte; A Larsen; TK Kvien; M Schattenkirchner; P Nash; C Oed; I Loew-Friedrich
Treatment of active rheumatoid arthritis with leflunomide: two year follow up of a double blind, placebo controlled trial versus sulfasalazine.
Annals of the rheumatic diseases 2001;60(10):913-23.
2001: Victor R Preedy; Wassif S Wassif; D Baldwin; J Jones; G Falkous; Jaspaul S Marway; David Mantle; David Scott
Skeletal muscle protein loss due to D-penicillamine results from reduced protein synthesis.
The international journal of biochemistry & cell biology 2001;33(10):1013-26.
2001: David Scott
Guidelines for arthritis: ten years on.
Clinical medicine (London, England) 2001;1(5):389-91.
2001: E H S Choy; David Scott; Gabrielle Kingsley; S Thomas; A G Murphy; Norman A Staines; Gabriel S Panayi
Control of rheumatoid arthritis by oral tolerance.
Arthritis and rheumatism 2001;44(9):1993-7.
2001: P Fisher; David Scott
A randomized controlled trial of homeopathy in rheumatoid arthritis.
Rheumatology (Oxford, England) 2001;40(9):1052-5.
2001: Joachim R Kalden; David Scott; Josef S Smolen; M Schattenkirchner; B Rozman; B D Williams; TK Kvien; P Jones; R B Williams; C Oed; R Rosenburg
Improved functional ability in patients with rheumatoid arthritis--longterm treatment with leflunomide versus sulfasalazine. European Leflunomide Study Group.
The Journal of rheumatology 2001;28(9):1983-91.
2001: Y L Chung; H L Mitchell; DA Houssien; H Al-Mahrouki; A J Carr; David Scott
A comparative study of outcome in myositis and other musculoskeletal disorders assessed using the Nottingham health profile.
Clinical and experimental rheumatology 2001;19(4):447-50.
2001: Paul Emery; J Y Reginster; T Appelboom; Ferdinand C Breedveld; E Edelmann; J Kekow; M Malaise; EM Mola; C Montecucco; M Sanda; J Sany; David Scott; U Serni; G Seydoux
WHO Collaborating Centre consensus meeting on anti-cytokine therapy in rheumatoid arthritis.
Rheumatology (Oxford, England) 2001;40(6):699-702.
2001: Nicolò Pipitone; David Scott
Magnetic pulse treatment for knee osteoarthritis: a randomised, double-blind, placebo-controlled study.
Current medical research and opinion 2001;17(3):190-6.
2001: T Garrood; David Scott
Combination therapy with disease modifying anti-rheumatic drugs in rheumatoid arthritis.
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 2001;15(8):543-61.
2001: A Larsen; TK Kvien; M Schattenkirchner; R Rau; David Scott; Josef S Smolen; B Rozman; R Westhovens; M Tikly; C Oed; R Rosenburg
Slowing of disease progression in rheumatoid arthritis patients during long-term treatment with leflunomide or sulfasalazine.
Scandinavian journal of rheumatology 2001;30(3):135-42.
2000: David Scott; T Garrood
Quality of life measures: use and abuse.
Baillière's best practice & research. Clinical rheumatology 2000;14(4):663-87.
2000: J Guilar; I Wamuo; E H Choy; M Hossain; David Scott
Who is referred for specialist rheumatology care?
Rheumatology (Oxford, England) 2000;39(11):1292-4.
2000: Daniel E Furst; Ferdinand C Breedveld; Gerd R Burmester; J J Crofford; P Emery; M Feldmann; JR Kalden; Arthur F Kavanaugh; Edward C Keystone; LG Klareskog; PE Lipsky; RN Maini; A S Russell; David Scott; JS Smolen; L B A Van De Putte; T L Visher; Michael H Weisman
Updated consensus statement on tumour necrosis factor blocking agents for the treatment of rheumatoid arthritis (May 2000).
Annals of the rheumatic diseases 2000;59 Suppl 1():i1-2.
2000: David Scott; H Berry; H Capell; J Coppock; T Daymond; D V Doyle; L Fernandes; B Hazleman; J Hunter; E C Huskisson; A Jawad; R Jubb; T Kennedy; P McGill; F Nichol; J Palit; M Webley; A Woolf; J Wotjulewski
The long-term effects of non-steroidal anti-inflammatory drugs in osteoarthritis of the knee: a randomized placebo-controlled trial.
Rheumatology (Oxford, England) 2000;39(10):1095-101.
2000: Guy H Carpenter; Gordon B Proctor; CL Pankhurst; J O'Donohue; David Scott; M P Hunnable
Sialochemical markers of salivary gland involvement with Sjögren's syndrome secondary to rheumatoid arthritis and primary biliary cirrhosis.
Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 2000;29(9):452-9.
2000: David Scott
Prognostic factors in early rheumatoid arthritis.
Rheumatology (Oxford, England) 2000;39 Suppl 1():24-9.
2000: David Scott; R H Palmer
Safety and efficacy of nabumetone in osteoarthritis: emphasis on gastrointestinal safety.
Alimentary pharmacology & therapeutics 2000;14(4):443-52.
2000: David Scott; K Pugner; K Kaarela; D V Doyle; A Woolf; J Holmes; K Hieke
The links between joint damage and disability in rheumatoid arthritis.
Rheumatology (Oxford, England) 2000;39(2):122-32.
2000: I Pande; T W O'Neill; C Pritchard; David Scott; A D Woolf
Bone mineral density, hip axis length and risk of hip fracture in men: results from the Cornwall Hip Fracture Study.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2000;11(10):866-70.
1999: James R O'Dell; David Scott
Rheumatoid arthritis: new developments in the use of existing therapies.
Rheumatology (Oxford, England) 1999;38 Suppl 2():24-6.
1999: David Scott; S Farrow; S I Yeo
Early developments in combination therapy.
Clinical and experimental rheumatology 1999;17(6 Suppl 18):S8-12.
1999: Jeremy A Tibble; Gudmundur Sigthorsson; Russell Foster; David Scott; Magne Kristoffer Fagerhol; Arne G Roseth; Ingvar Bjarnason
High prevalence of NSAID enteropathy as shown by a simple faecal test.
Gut 1999;45(3):362-6.
1999: Esmeralda T H Molenaar; Maarten Boers; Désirée van der Heijde; G Alarcón; B Bresnihan; M Cardiel; John Edmonds; David T Felson; D E Furst; John Kirwan; Marissa Lassere; H Paulus; R Rau; P L C M van Riel; David Scott; Lee Simon; Vibeke Strand
Imaging in rheumatoid arthritis: results of group discussions.
The Journal of rheumatology 1999;26(3):749-51.
1999: John Edmonds; Ariane Saudan; Marissa Lassere; David Scott
Introduction to reading radiographs by the Scott modification of the Larsen method.
The Journal of rheumatology 1999;26(3):740-2.
1999: Josef S Smolen; Joachim R Kalden; David Scott; B Rozman; TK Kvien; A Larsen; I Loew-Friedrich; C Oed; R Rosenburg
Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial. European Leflunomide Study Group.
Lancet 1999;353(9149):259-66.
1999: David Scott; P Gishen
Radiological assessment of hip osteoarthritis.
Lancet 1999;353(9147):87-8.
1999: David Scott
Leflunomide improves quality of life in rheumatoid arthritis.
Scandinavian journal of rheumatology. Supplement 1999;112():23-9.
1999: D A Houssien; G Stucki; David Scott
A patient-derived disease activity score can substitute for a physician-derived disease activity score in clinical research.
Rheumatology (Oxford, England) 1999;38(1):48-52.
1998: mahmud taher; Sivagurunathan Somasundaram; Gudmundur Sigthorsson; Robert J Simpson; Shaik Rafi; Russell Foster; Ignatius A Tavares; Arne G Roseth; A J Hutt; Molly Jacob; J Pacy; David Scott; JM Wrigglesworth; Ingvar Bjarnason
Enantiomers of flurbiprofen can distinguish key pathophysiological steps of NSAID enteropathy in the rat.
Gut 1998;43(6):775-82.
1998: Michael V Hurley; David Scott
Improvements in quadriceps sensorimotor function and disability of patients with knee osteoarthritis following a clinically practicable exercise regime.
British journal of rheumatology 1998;37(11):1181-7.
1998: Gudmundur Sigthorsson; Jeremy A Tibble; J Hayllar; I Menzies; A Macpherson; R Moots; David Scott; M J Gumpel; Ingvar Bjarnason
Intestinal permeability and inflammation in patients on NSAIDs.
Gut 1998;43(4):506-11.
1998: C J McCabe; Ron Akehurst; J Kirsch; Malcolm Whitfield; M Backhouse; A D Woolf; David Scott; P Emery; I Haslock
Choice of NSAID and management strategy in rheumatoid arthritis and osteoarthritis. The impact on costs and outcomes in the UK.
PharmacoEconomics 1998;14(2):191-9.
1998: Deborah Symmons; M A Jones; David Scott; P Prior
Longterm mortality outcome in patients with rheumatoid arthritis: early presenters continue to do well.
The Journal of rheumatology 1998;25(6):1072-7.
1998: David Scott; M Shipley; A Dawson; S Edwards; Deborah Symmons; A D Woolf
The clinical management of rheumatoid arthritis and osteoarthritis: strategies for improving clinical effectiveness.
British journal of rheumatology 1998;37(5):546-54.
1998: DA Houssien; David Scott; T Jonsson
Smoking, rheumatoid factors, and rheumatoid arthritis.
Annals of the rheumatic diseases 1998;57(3):175-6.
1998: G O Storey; David Scott
Arthritis associated with venereal disease in nineteenth century London.
Clinical rheumatology 1998;17(6):500-4.
1998: DA Houssien; David Scott
Early referral and outcome in rheumatoid arthritis.
Scandinavian journal of rheumatology 1998;27(4):300-2.
1998: DA Houssien; T Jónsson; E Davies; David Scott
Rheumatoid factor isotypes, disease activity and the outcome of rheumatoid arthritis: comparative effects of different antigens.
Scandinavian journal of rheumatology 1998;27(1):46-53.
1997: Y L Chung; E C Smith; S C Williams; W S Wassif; J R Salisbury; Andrew Simmons; D C Howlett; David Scott
In vivo proton magnetic resonance spectroscopy in polymyositis and dermatomyositis: a preliminary study.
European journal of medical research 1997;2(11):483-7.
1997: Michael V Hurley; David Scott; J Rees; Di J Newham
Sensorimotor changes and functional performance in patients with knee osteoarthritis.
Annals of the rheumatic diseases 1997;56(11):641-8.
1997: DA Houssien; T Jonsson; E Davies; David Scott
Clinical significance of IgA rheumatoid factor subclasses in rheumatoid arthritis.
The Journal of rheumatology 1997;24(11):2119-22.
1997: Sivagurunathan Somasundaram; Shaik Rafi; J Hayllar; Gudmundur Sigthorsson; Molly Jacob; AB Price; A Macpherson; T Mahmod; David Scott; JM Wrigglesworth; Ingvar Bjarnason
Mitochondrial damage: a possible mechanism of the "topical" phase of NSAID induced injury to the rat intestine.
Gut 1997;41(3):344-53.
1997: Marissa Lassere; D Houssein; David Scott; John Edmonds
Reference curves of radiographic damage in patients with rheumatoid arthritis: application of quantile regression and fractional polynomials.
The Journal of rheumatology 1997;24(7):1288-94.
1997: David Scott; L Laasonen; Francesco Priolo; D A Houssien; L Bacarini; Alfonso CERASE; M Cammisa
The radiological assessment of rheumatoid arthritis.
Clinical and experimental rheumatology 1997;15 Suppl 17():S53-61.
1997: Sivagurunathan Somasundaram; Shaik Rafi; Molly Jacob; Gudmundur Sigthorsson; mahmud taher; Roy Sherwood; AB Price; A Macpherson; David Scott; JM Wrigglesworth; Ingvar Bjarnason
Intestinal tolerability of nitroxybutyl-flurbiprofen in rats.
Gut 1997;40(5):608-13.
1997: E H Choy; David Scott
Drug treatment of rheumatic diseases in the 1990s. Achievements and future developments.
Drugs 1997;53(3):337-48.
1997: David Scott
Clinical guidelines for management.
Baillière's clinical rheumatology 1997;11(1):157-79.
1997: D A Houssien; S P McKenna; David Scott
The Nottingham Health Profile as a measure of disease activity and outcome in rheumatoid arthritis.
British journal of rheumatology 1997;36(1):69-73.
1996: David Scott; D A Houssien
Clinical and laboratory assessments in rheumatoid arthritis and osteoarthritis.
British journal of rheumatology 1996;35 Suppl 3():6-9.
1996: mahmud taher; Shaik Rafi; David Scott; JM Wrigglesworth; Ingvar Bjarnason
Nonsteroidal antiinflammatory drugs and uncoupling of mitochondrial oxidative phosphorylation.
Arthritis and rheumatism 1996;39(12):1998-2003.
1996: David Scott; E H Choy; A Greeves; D Isenberg; D Kassinor; E Rankin; E C Smith
Standardising joint assessment in rheumatoid arthritis.
Clinical rheumatology 1996;15(6):579-82.
1996: David Scott; D A Houssien
Joint assessment in rheumatoid arthritis.
British journal of rheumatology 1996;35 Suppl 2():14-8.
1996: Victor R Preedy; J S Marway; D Baldwin; A G Paice; J Jones; W S Wassif; David Scott
Experimental D-penicillamine-induced myopathy.
Biochemical Society transactions 1996;24(2):266S.
1996: mahmud taher; David Scott; I Bjarnason
A unifying hypothesis for the mechanism of NSAID related gastrointestinal toxicity.
Annals of the rheumatic diseases 1996;55(4):211-3.
1996: E C Smith; H Berry; David Scott
The clinical need for an acute rheumatology referral service.
British journal of rheumatology 1996;35(4):389-91.
1995: R A Jacobs; D Perrett; J M Axon; K E Herbert; David Scott
Rheumatoid synovial cell proliferation, transformation and fibronectin secretion in culture.
Clinical and experimental rheumatology 1995;13(6):717-23.
1995: mahmud taher; M Comer; K Roberts; H Berry; David Scott
Clinical implications of patients' knowledge.
Clinical rheumatology 1995;14(6):627-30.
1995: M Comer; David Scott; D V Doyle; E C Huskisson; A Hopkins
Are slow-acting anti-rheumatic drugs monitored too often? An audit of current clinical practice.
British journal of rheumatology 1995;34(10):966-70.
1995: David Scott; A F Long; A Silman
Disease outcomes in rheumatology.
British journal of rheumatology 1995;34(8):704-6.
1995: E H Choy; David Scott
Prognostic markers in rheumatoid arthritis and classification of antirheumatic therapies.
Drugs 1995;50 Suppl 1():15-25.
1995: David Scott; D A Houssien; L Laasonen
Proposed modification to Larsen's scoring methods for hand and wrist radiographs.
British journal of rheumatology 1995;34(1):56.
1994: G O Storey; M Comer; David Scott
Chronic arthritis before 1876: early British cases suggesting rheumatoid arthritis.
Annals of the rheumatic diseases 1994;53(9):557-60.
1994: Anthony S Russell; J Darmawan; David Scott; P M Brooks; O Hubscher
Guidelines for use of antirheumatic drugs.
The Journal of rheumatology. Supplement 1994;41():79-81.
1994: David Scott; A O Adebajo; S el Badaway; J Kirwan; L B van de Putte; P L van Riel
DC-ART: preventing or significantly decreasing the rate of progression of structural joint damage.
The Journal of rheumatology. Supplement 1994;41():36-40.
1994: V Strand; David Scott; G S Panayi
Evaluating biologic agents in rheumatoid arthritis: a framework for clinical trials.
The Journal of rheumatology 1994;21(8):1390-2.
1994: A F Long; David Scott
Measuring health status and outcomes in rheumatoid arthritis within routine clinical practice.
British journal of rheumatology 1994;33(7):682-5.
1994: J P Larbre; J A Da Silva; Adrian R Moore; I T James; David Scott; Derek A Willoughby
Cartilage contribution to gender differences in joint disease progression. A study with rat articular cartilage.
Clinical and experimental rheumatology 1994;12(4):401-8.
1994: J A Da Silva; J P Larbre; M P Seed; Maurizio Cutolo; Barbara Villaggio; David Scott; Derek A Willoughby
Sex differences in inflammation induced cartilage damage in rodents. The influence of sex steroids.
The Journal of rheumatology 1994;21(2):330-7.
1993: K D Bardhan; I Bjarnason; David Scott; W M Griffin; G C Fenn; Michael J Shield; Steve V Morant
The prevention and healing of acute non-steroidal anti-inflammatory drug-associated gastroduodenal mucosal damage by misoprostol.
British journal of rheumatology 1993;32(11):990-5.
1993: Deborah Symmons; P Maddison; D Isenberg; David Scott
Communication channels of the Arthritis and Rheumatism Council--the role of the Honorary Medical Secretaries.
British journal of rheumatology 1993;32(11):947-8.
1993: L J Goldby; David Scott
The way forward for hydrotherapy.
British journal of rheumatology 1993;32(9):771-3.
1993: David V Doyle; D Perrett; O J Foster; M Ensor; David Scott
The long-term use of D-penicillamine for treating rheumatoid arthritis: is continuous therapy necessary?
British journal of rheumatology 1993;32(7):614-7.
1993: J A da Silva; Paul Colville-Nash; Tim D Spector; David Scott; Derek A Willoughby
Inflammation-induced cartilage degradation in female rodents. Protective role of sex hormones.
Arthritis and rheumatism 1993;36(7):1007-13.
1993: J A Da Silva; J P Larbre; Tim D Spector; L A Perry; David Scott; Derek A Willoughby
Protective effect of androgens against inflammation induced cartilage degradation in male rodents.
Annals of the rheumatic diseases 1993;52(4):285-91.
1993: J P Edmonds; David Scott; D E Furst; H E Paulus
New classification of antirheumatic drugs. The evolution of a concept.
The Journal of rheumatology 1993;20(3):585-7.
1993: David Scott
A simple index to assess disease activity in rheumatoid arthritis.
The Journal of rheumatology 1993;20(3):582-4.
1993: David Scott
European preferences in assessing rheumatoid arthritis.
The Journal of rheumatology 1993;20(3):542.
1993: J P Edmonds; David Scott; D E Furst; P Brooks; H E Paulus
Antirheumatic drugs: a proposed new classification.
Arthritis and rheumatism 1993;36(3):336-9.
1993: Adrian R Moore; H Iwamura; J P Larbre; David Scott; Derek A Willoughby
Cartilage degradation by polymorphonuclear leucocytes: in vitro assessment of the pathogenic mechanisms.
Annals of the rheumatic diseases 1993;52(1):27-31.
1992: David Scott; R L Wolman
Rest or exercise in inflammatory arthritis?
British journal of hospital medicine 1992;48(8):445, 447.
1992: Anne Ballinger; David Scott
Rheumatology and the gut.
British journal of hospital medicine 1992;48(7):378-87.
1992: Tim D Spector; L Woodward; G M Hall; A Hammond; A Williams; M G Butler; I T James; D J Hart; P W Thompson; David Scott
Keratan sulphate in rheumatoid arthritis, osteoarthritis, and inflammatory diseases.
Annals of the rheumatic diseases 1992;51(10):1134-7.
1992: David Scott; G S Panayi; P L van Riel; J Smolen; L B van de Putte
Disease activity in rheumatoid arthritis: preliminary report of the Consensus Study Group of the European Workshop for Rheumatology Research.
Clinical and experimental rheumatology 1992;10(5):521-5.
1992: Anne Ballinger; P J Kumar; David Scott
Misoprostol in the prevention of gastroduodenal damage in rheumatology.
Annals of the rheumatic diseases 1992;51(9):1089-93.
1992: P R Colville-Nash; David Scott
Angiogenesis and rheumatoid arthritis: pathogenic and therapeutic implications.
Annals of the rheumatic diseases 1992;51(7):919-25.
1992: H A Waller; M G Butler; J G McClean; G S Dowd; David Scott
Localisation of fibronectin mRNA in the rheumatoid synovium by in situ hybridisation.
Annals of the rheumatic diseases 1992;51(6):735-40.
1992: S Donnelly; David Scott; P Emery
Management of early inflammatory arthritis. The long-term outcome and justification for early treatment.
Baillière's clinical rheumatology 1992;6(2):251-60.
1992: I D Griffiths; I Haslock; R Amos; David Scott
Royal College of Physicians Standing Committee on Rheumatology, and British Society for Rheumatology. Guidelines for the Organization of Audit in Rheumatology: Combined Working Group Report.
British journal of rheumatology 1992;31(5):333-6.
1992: H E Paulus; David Scott; J P Edmonds
Classification of antirheumatic drugs. A new proposal.
Arthritis and rheumatism 1992;35(3):364-5.
1992: S Donnelly; R Amos; A J Norton; A Z Rohatiner; David Scott; Deborah Symmons
A patient with rheumatoid arthritis and lymphoma.
British journal of rheumatology 1992;31(2):107-12.
1992: David Scott; E C Huskisson
The course of rheumatoid arthritis.
Baillière's clinical rheumatology 1992;6(1):1-21.
1992: P Hiscott; H A Waller; Ian Grierson; M G Butler; David Scott
Local production of fibronectin by ectopic human retinal cells.
Cell and tissue research 1992;267(1):185-92.
1992: L L Bhusate; K E Herbert; David Scott; D Perrett
Increased DNA strand breaks in mononuclear cells from patients with rheumatoid arthritis.
Annals of the rheumatic diseases 1992;51(1):8-12.
1992: E C Huskisson; R M Bernstein; J S Coppock; P G Davies; D V Doyle; P R Platt; David Scott; R H Witherington; J A Wojtulewski
Enteric coated naproxen; a double blind trial comparing the tolerance of enteric coated and standard formulations.
European journal of rheumatology and inflammation 1992;12(2):27-30.
1992: S Donnelly; David Scott
The outcome of arthritis: measures of function, X-rays damage, pain and patients' satisfaction.
European journal of rheumatology and inflammation 1992;12(2):21-6.
1991: G M Hall; A Studnicke; E C Huskisson; David Scott
Rheumatoid nodules do not predict response to treatment with slow-acting anti-rheumatic drugs.
Clinical rheumatology 1991;10(4):384-7.
1991: J E Dacre; David Scott; J A Da Silva; G Welsh; E C Huskisson
Joint space in radiologically normal knees.
British journal of rheumatology 1991;30(6):426-8.
1991: Simon T Donell; D M Williamson; David Scott
Septic arthritis complicating hip osteoarthritis.
Annals of the rheumatic diseases 1991;50(10):722-3.
1991: David Scott
In a patient with inflammatory arthritis and pitting oedema of the ankles, is there any indication for venography?
British journal of rheumatology 1991;30(5):355.
1991: David Scott; D A Willoughby; D R Blake
Molecular insights into rheumatoid arthritis.
Molecular aspects of medicine 1991;12(5):341-94.
1991: L L Herbert; K E Herbert; R Jacobs; David Scott; D Perrett
The effect of aspirin on blood cell nucleotides in vivo.
Advances in experimental medicine and biology 1991;309B():357-8.
1991: David Scott; J MacCarthy
Variations between rheumatologists in using sulphasalazine.
European journal of rheumatology and inflammation 1991;11(2):46-52.
1991: E C Huskisson; David Scott
A clinical comparison of two leading non-steroidal anti-inflammatory drugs.
European journal of rheumatology and inflammation 1991;11(2):4-7.
1990: R Jacobs; M G Butler; David Scott
Antibodies to cardiolipin and intermediate filaments: a study of autoimmunity in rheumatoid arthritis.
Clinical rheumatology 1990;9(4):509-16.
1990: J E Dacre; David Scott; E C Huskisson
Lymphoedema of the limbs as an extra-articular feature of rheumatoid arthritis.
Annals of the rheumatic diseases 1990;49(9):722-4.
1990: K E Herbert; E Jeffery; David Scott
Effect of fibronectin on the Crithidia luciliae test for anti-double-stranded DNA antibodies.
Annals of the rheumatic diseases 1990;49(9):705-7.
1990: David Scott; E C Huskisson
Assessing combination therapy in rheumatoid arthritis: treatment with sulphasalazine and penicillamine.
British journal of rheumatology 1990;29(4):313-4.
1990: R A Jacobs; K E Herbert; David Scott
Synovial fluid fibronectin concentrations in chronic arthritis: influence of intra-articular steroids or oral non-steroidal anti-inflammatory drugs.
Annals of the rheumatic diseases 1990;49(7):569.
1990: G M Hall; S M Nasser; David Scott
Monoarthritis of the ankle in diabetes mellitus without neuropathy: a report of three cases.
Clinical rheumatology 1990;9(2):225-8.
1990: S Donovan; S Hawley; J MacCarthy; David Scott
Tolerability of enteric-coated sulphasalazine in rheumatoid arthritis: results of a co-operating clinics study.
British journal of rheumatology 1990;29(3):201-4.
1990: David Scott; A Greenwood; J Davies; P J Maddison; M C Maddison; N D Hall
Radiological progression in rheumatoid arthritis: do D-penicillamine and hydroxychloroquine have different effects?
British journal of rheumatology 1990;29(2):126-7.
1990: David Scott; J E Dacre; A Greenwood; L Treasure; E C Huskisson
Can we develop simple response criteria for slow acting antirheumatic drugs?
Annals of the rheumatic diseases 1990;49(3):196-8.
1990: E Treasure; David Scott; P M Katona; P Toon
Arthritis in inner city general practices.
The British journal of general practice : the journal of the Royal College of General Practitioners 1990;40(331):81-2.
1990: M W Robinson; K W Walton; D G Scott; David Scott
Diagnostic relevance of fibronectin in cryoprecipitates.
Rheumatology international 1990;10(2):81-4.
1990: David Scott
Etodolac and the treatment of arthritis.
European journal of rheumatology and inflammation 1990;10(1):1-2.
1990: David Scott; I Haslock
Measuring performance in clinical rheumatology.
Annals of the rheumatic diseases 1990;49(1):3-5.
1990: K E Herbert; P I Mapp; A M Griffiths; Peter A Revell; David Scott
Synovial fluid fibronectin fragments: no evidence for a mitogenic effect on fibroblasts.
Rheumatology international 1990;10(5):199-201.
1989: A M Griffiths; K E Herbert; D Perrett; David Scott
Fragmented fibronectin and other synovial fluid proteins in chronic arthritis: their relation to immune complexes.
Clinica chimica acta; international journal of clinical chemistry 1989;184(2):133-46.
1989: G O Storey; David Scott
Use of disablement resettlement officers by patients with musculoskeletal disorders.
International disability studies 1989;11(3):108-9.
1989: M W Robinson; D G Scott; Paul A Bacon; K W Walton; J S Coppock; David Scott
What proteins are present in polyethylene glycol precipitates from rheumatic sera?
Annals of the rheumatic diseases 1989;48(6):496-501.
1989: A Allan; J Wyke; R N Allan; P Morel; M Robinson; David Scott; J Alexander-Williams
Plasma fibronectin in Crohn's disease.
Gut 1989;30(5):627-33.
1989: M Soden; J Hassan; David Scott; J G Hanly; M Moriarty; A Whelan; Conleth Feighery; Barry Bresnihan
Lymphoid irradiation in intractable rheumatoid arthritis. Long-term followup of patients treated with 750 rads or 2,000 rads.
Arthritis and rheumatism 1989;32(5):523-30.
1989: J E Dacre; N Beeney; David Scott
Injections and physiotherapy for the painful stiff shoulder.
Annals of the rheumatic diseases 1989;48(4):322-5.
1989: David Scott; Peter T Dawes; E Tunn; P D Fowler; M F Shadforth; J Fisher; S Clarke; M Collins; P Jones; A J Popert
Combination therapy with gold and hydroxychloroquine in rheumatoid arthritis: a prospective, randomized, placebo-controlled study.
British journal of rheumatology 1989;28(2):128-33.
1989: M L Jenkinson; M R Bliss; A T Brain; David Scott
Peripheral arthritis in the elderly: a hospital study.
Annals of the rheumatic diseases 1989;48(3):227-31.
1989: David Scott; Tim D Spector; T Pullar; B McConkey
What should we hope to achieve when treating rheumatoid arthritis?
Annals of the rheumatic diseases 1989;48(3):256-61.
1989: M L Jenkinson; M R Bliss; A T Brain; David Scott
Rheumatoid arthritis and senile dementia of the Alzheimer's type.
British journal of rheumatology 1989;28(1):86-8.
1989: P I Williams; J Hosie; David Scott
Etodolac therapy for osteoarthritis: a double-blind, placebo-controlled trial.
Current medical research and opinion 1989;11(7):463-70.
1989: K E Herbert; David Scott; D Perrett
Determination of cytidine deaminase activity in synovial fluid by HPLC.
Journal of pharmaceutical and biomedical analysis 1989;7(6):737-45.
1988: A Williams; David Scott; A Greenwood; E C Huskisson
The clinical value of measuring immunoglobulins when assessing penicillamine therapy in rheumatoid arthritis.
Clinical rheumatology 1988;7(3):347-53.
1988: Tim D Spector; David Scott
What happens to patients with rheumatoid arthritis? The long-term outcome of treatment.
Clinical rheumatology 1988;7(3):315-30.
1988: David Scott; J E Dacre
Adverse reactions to sulfasalazine: the British experience.
The Journal of rheumatology. Supplement 1988;16():17-21.
1988: David Scott; R C Butler; M M Irani
New consultant's workshop in rheumatology.
British journal of rheumatology 1988;27(4):325-6.
1988: M G Butler; A J D'Ardenne; David Scott
P component in the synovium in rheumatoid and osteoarthritis.
Annals of the rheumatic diseases 1988;47(6):463-7.
1988: A Sadana; D Merrick-Thomas; David Scott
Vasculitis in Reiter's syndrome.
Clinical rheumatology 1988;7(1):114.
1988: David Scott; M S Irani; R C Butler
What do newly appointed rheumatologists think?
Lancet 1988;1(8577):113.
1988: David Scott; J G Hanly; M Moriarty; Barry Bresnihan
The effect of lymphoid irradiation on the progression of joint damage in intractable rheumatoid arthritis.
Arthritis and rheumatism 1988;31(1):147-8.
1988: K E Herbert; David Scott; D Perrett
Nucleosides and bases in synovial fluid from patients with rheumatoid arthritis and osteoarthritis.
Clinical science (London, England : 1979) 1988;74(1):97-9.
1988: David Scott; A Greenwood; R Bryans; E C Huskisson
Progressive joint damage during penicillamine therapy for rheumatoid arthritis.
Rheumatology international 1988;8(3):135-9.
1987: K E Herbert; J S Coppock; A M Griffiths; A Williams; M W Robinson; David Scott
Fibronectin and immune complexes in rheumatic diseases.
Annals of the rheumatic diseases 1987;46(10):734-40.
1987: David Scott; P T Dawes; M Collins; R Stone
ELISA assays for IgM and IgG rheumatoid factors: their clinical correlations during therapy with slow-acting anti-rheumatic drugs.
Clinical rheumatology 1987;6(3):358-68.
1987: David Scott; Deborah Symmons; B L Coulton; A J Popert
Long-term outcome of treating rheumatoid arthritis: results after 20 years.
Lancet 1987;1(8542):1108-11.
1987: David Scott
Clinical measurements in rheumatology.
British journal of rheumatology 1987;26(2):81-3.
1987: R Stone; J S Coppock; P T Dawes; P A Bacon; David Scott
Clinical value of ELISA assays for IgM and IgG rheumatoid factors.
Journal of clinical pathology 1987;40(1):107-11.
1987: M Farr; Paul A Bacon; J Coppock; David Scott
Long term experience of salazopyrin EN in rheumatoid arthritis (RA).
Scandinavian journal of rheumatology. Supplement 1987;64():37-47.
1986: David Scott; Peter T Dawes; P D Fowler; M F Shadforth
Calculating radiological progression in rheumatoid arthritis.
Clinical rheumatology 1986;5(4):445-9.
1986: D G Scott; M Salmon; David Scott; A Blann; P A Bacon; K W Walton; C D Oakland; G F Slaney
Takayasu's arteritis: a pathogenetic role for cytotoxic T lymphocytes?
Clinical rheumatology 1986;5(4):517-22.
1986: Peter T Dawes; P D Fowler; R Jackson; M Collins; M F Shadforth; R Stone; David Scott
Prediction of progressive joint damage in patients with rheumatoid arthritis receiving gold or D-penicillamine therapy.
Annals of the rheumatic diseases 1986;45(11):945-9.
1986: S D Carter; David Scott; C J Elson
Fibronectin binding with immunoglobulin aggregates and its association with rheumatic disorders.
British journal of rheumatology 1986;25(4):353-8.
1986: J D Williams; David Scott; F B DeBrito; D A Willoughby; E C Huskisson
Rheumatoid inflammation and joint destruction: cause and effect or parallel phenomena?
Agents and actions 1986;18(5-6):538-43.
1986: David Scott; B L Coulton; A J Popert
Long term progression of joint damage in rheumatoid arthritis.
Annals of the rheumatic diseases 1986;45(5):373-8.
1986: Deborah Symmons; P Prior; David Scott; R Brown; C F Hawkins
Factors influencing mortality in rheumatoid arthritis.
Journal of chronic diseases 1986;39(2):137-45.
1986: J S Coppock; David Scott; S D Carter; T M Moreland; M W Robinson
Fibronectin in polyethylene glycol precipitates: evidence for a role in immune complexes.
Rheumatology international 1986;6(2):79-83.
1986: P T Dawes; D H Smith; David Scott
Massive eosinophilia in rheumatoid arthritis: report of four cases.
Clinical rheumatology 1986;5(1):62-5.
1986: A Y Al-Duaij; F B De Brito; A D Sedgwick; David Scott; Derek A Willoughby
Susceptibility of cartilage to damage by immunological inflammation.
International archives of allergy and applied immunology 1986;80(4):435-7.
1986: David Scott; M Farr
Assessing the progression of joint damage in rheumatoid arthritis.
Drugs 1986;32 Suppl 1():63-70.
1985: David Scott; M W Robinson; S Yoshino
Fibronectin in chronic inflammation: studies using the rat air pouch model of chronic allergic inflammation.
British journal of experimental pathology 1985;66(5):519-26.
1985: David Scott; R E Gibbins
The results of hand surgery in rheumatoid arthritis.
The Practitioner 1985;229(1404):581-4.
1985: K A Grindulis; David Scott; M W Robinson; P A Bacon; B McConkey
Serum amyloid A protein during the treatment of rheumatoid arthritis with second-line drugs.
British journal of rheumatology 1985;24(2):158-63.
1985: C S Barker; Deborah Symmons; David Scott; P A Bacon
Joint sepsis as a complication of sero-negative arthritis.
Clinical rheumatology 1985;4(1):51-4.
1985: David Scott; P Bracken; P A Bacon; G Husby
Amyloid 'degrading factor activity': a non-specific calcium-mediated effect.
Clinical science (London, England : 1979) 1985;68(3):333-9.
1985: David Scott; B L Coulton; P A Bacon; A J Popert
Methods of X-ray assessment in rheumatoid arthritis: a re-evaluation.
British journal of rheumatology 1985;24(1):31-9.
1985: David Scott; Peter T Dawes; P D Fowler; K A Grindulis; M Shadforth; P A Bacon
Anti-rheumatic drugs and joint damage in rheumatoid arthritis.
The Quarterly journal of medicine 1985;54(213):49-59.
1985: David Scott; P A Bacon
Joint damage in rheumatoid arthritis: radiological assessments and the effects of anti-rheumatic drugs.
Rheumatology international 1985;5(5):193-9.
1985: David Scott; S D Carter; J S Coppock; M Robinson; K W Walton
Differences between plasma and synovial fluid fibronectin.
Rheumatology international 1985;5(2):49-54.
1984: M Kalra; A E Blake; David Scott; A J Popert
Nitrogen mustard and methylprednisolone in severe rheumatoid arthritis.
Clinical rheumatology 1984;3(4):554-5.
1984: D J Unsworth; David Scott; K W Walton; J A Walker-Smith; E J Holborow
Failure of R1 type anti-reticulin antibody to react with fibronectin, collagen type III or the non-collagenous reticulin component (NCRC).
Clinical and experimental immunology 1984;57(3):609-13.
1984: David Scott; M Salmon; C J Morris; A C Wainwright; K W Walton
Laminin and vascular proliferation in rheumatoid arthritis.
Annals of the rheumatic diseases 1984;43(4):551-5.
1984: P Prior; Deborah Symmons; David Scott; R Brown; C F Hawkins
Cause of death in rheumatoid arthritis.
British journal of rheumatology 1984;23(2):92-9.
1984: David Scott; M Salmon; K W Walton
Reticulin and its related structural connective tissue proteins in the rheumatoid synovium.
Histopathology 1984;8(3):469-79.
1984: Deborah Symmons; M Ahern; P A Bacon; C F Hawkins; P L Amlot; E L Jones; P Prior; David Scott
Lymphoproliferative malignancy in rheumatoid arthritis: a study of 20 cases.
Annals of the rheumatic diseases 1984;43(2):132-5.
1984: P Prior; Deborah Symmons; C F Hawkins; David Scott; R Brown
Cancer morbidity in rheumatoid arthritis.
Annals of the rheumatic diseases 1984;43(2):128-31.
1984: S Yoshino; P A Bacon; D R Blake; David Scott; A C Wainwright; K W Walton
A model of persistent antigen-induced chronic inflammation in the rat air pouch.
British journal of experimental pathology 1984;65(2):201-14.
1984: K W Walton; T J Almond; Morton J Robinson; David Scott
An experimental model for the study of the opsonic activity of fibronectin in the clearance of intravascular complexes.
British journal of experimental pathology 1984;65(2):191-200.
1984: G R Struthers; David Scott; M Farr
Septic arthritis and thigh abscess after dilatation and curettage.
Clinical rheumatology 1984;3(1):71-3.
1984: David Scott; K W Walton
The significance of fibronectin in rheumatoid arthritis.
Seminars in arthritis and rheumatism 1984;13(3):244-54.
1984: David Scott; K A Grindulis; G R Struthers; B L Coulton; A J Popert; P A Bacon
Progression of radiological changes in rheumatoid arthritis.
Annals of the rheumatic diseases 1984;43(1):8-17.
1984: M C Chellingworth; M Salmon; David Scott; P A Bacon
The significance of IgM antinuclear antinuclear antibody in rheumatoid arthritis and other connective tissue diseases.
Rheumatology international 1984;4(1):23-5.
1983: G R Struthers; David Scott; D G Scott; P A Bacon
Partial finger loss: an indicator of severe connective tissue disease with overlap features.
British journal of rheumatology 1983;22(4):213-7.
1983: M Farr; C Morris; C A Hollywell; David Scott; K W Walton; Paul A Bacon
Amyloidosis in Whipple's arthritis.
Journal of the Royal Society of Medicine 1983;76(11):963-5.
1983: G R Struthers; David Scott; Paul A Bacon; K W Walton
Musculoskeletal disorders in patients with hyperlipidaemia.
Annals of the rheumatic diseases 1983;42(5):519-23.
1983: M Farr; David Scott; T J Constable; R J Hawker; C F Hawkins; J Stuart
Thrombocytosis of active rheumatoid disease.
Annals of the rheumatic diseases 1983;42(5):545-9.
1983: David Scott; T J Almond; K W Walton; I M Hunneyball
The role of fibronectin in the pathogenesis of antigen-induced arthritis in the rabbit.
The Journal of pathology 1983;141(2):143-56.
1983: D H Smith; David Scott; G C Zaphiropoulos
Eosinophilia in D-penicillamine therapy.
Annals of the rheumatic diseases 1983;42(4):408-10.
1983: David Scott; G Marhaug; G Husby
Comparative studies of the high molecular weight amyloid fibril proteins and similar components from normal tissues.
Clinical and experimental immunology 1983;52(3):693-701.
1983: R Kitt; David Scott; B L Coulton; A J Popert
Nitrogen mustard in severe rheumatoid arthritis.
Clinical rheumatology 1983;2(1):27-35.
1983: G R Struthers; David Scott; D G Scott
The use of 'alternative treatments' by patients with rheumatoid arthritis.
Rheumatology international 1983;3(4):151-2.
1983: K A Grindulis; David Scott; G R Struthers
The assessment of radiological changes in the hands and wrists in rheumatoid arthritis.
Rheumatology international 1983;3(1):39-42.
1983: David Scott; B L Coulton; J H Chapman; P A Bacon; A J Popert
The long-term effects of treating rheumatoid arthritis.
Journal of the Royal College of Physicians of London 1983;17(1):79-85.
1983: C J Morris; M Farr; C A Hollywell; C F Hawkins; David Scott; K W Walton
Ultrastructure of the synovial membrane in seronegative inflammatory arthropathies.
Journal of the Royal Society of Medicine 1983;76(1):27-31.
1982: David Scott; D Scott; P Bacon
Therapeutic progress--review VI. Treatment of rheumatoid arthritis.
Journal of clinical and hospital pharmacy 1982;7(4):217-29.
1982: David Scott; S Roden; T Marshall; M J Kendall
Variations in responses to non-steroidal anti-inflammatory drugs.
British journal of clinical pharmacology 1982;14(5):691-4.
1982: L Takavarasha; David Scott; T J Constable
A pharmacist's audit of antirheumatic drugs.
Rheumatology and rehabilitation 1982;21(4):201-5.
1982: David Scott; T J Almond; S N Naqvi; D J Lea; R Stone; K W Walton
The significance of fibronectin in cryoprecipitation in rheumatoid arthritis and other diseases.
The Journal of rheumatology 1982;9(4):514-8.
1982: D J Unsworth; David Scott; T J Almond; H K Beard; E J Holborow; K W Walton
Studies on reticulin. I: Serological and immunohistological investigations of the occurrence of collagen type III, fibronectin and the non-collagenous glycoprotein of Pras and Glynn in reticulin.
British journal of experimental pathology 1982;63(2):154-66.
1982: A J Popert; David Scott; A C Wainwright; K W Walton; N Williamson; J H Chapman
Frequency of occurrence, mode of development, and significance or rice bodies in rheumatoid joints.
Annals of the rheumatic diseases 1982;41(2):109-17.
1982: David Scott; S Roden; T S Low-Beer; L Takavarasha
Prescribing non-steroidal anti-inflammatory drugs: a prospective study of patients' preference.
Postgraduate medical journal 1982;58(677):146-8.
1982: J P Delamere; David Scott; D D Felix-Davies
Thyroid dysfunction and rheumatic diseases.
Journal of the Royal Society of Medicine 1982;75(2):102-6.
1982: M Farr; David Scott; P A Bacon
Sulphasalazine desensitisation in rheumatoid arthritis.
British medical journal (Clinical research ed.) 1982;284(6309):118.
1982: David Scott; J P Delamere; L P Mackintosh; S Jobson
Familial cheiroarthropathy without juvenile onset diabetes mellitus.
Rheumatology international 1982;2(3):141-3.
1982: David Scott; M Farr; A P Crockson; K W Walton
Synovial fluid and plasma fibronectin levels in rheumatoid arthritis.
Clinical science (London, England : 1979) 1982;62(1):71-6.
1981: David Scott; M Farr; C F Hawkins; R Wilkinson; A M Bold
Serum calcium levels in rheumatoid arthritis.
Annals of the rheumatic diseases 1981;40(6):580-3.
1981: David Scott; J P Delamere; K W Walton
The distribution of fibronectin in the pannus in rheumatoid arthritis.
British journal of experimental pathology 1981;62(4):362-8.
1981: David Scott; C J Morris; A E Blake; T S Low-Beer; K W Walton
Distribution of fibronectin in the rectal mucosa.
Journal of clinical pathology 1981;34(7):749-58.
1981: David Scott; J P Delamere; L J Jones; K W Walton
Significance of laminar antikeratin antibodies to rat oesophagus in rheumatoid arthritis.
Annals of the rheumatic diseases 1981;40(3):267-71.
1981: David Scott; A C Wainwright; K W Walton; N Williamson
Significance of fibronectin in rheumatoid arthritis and osteoarthrosis.
Annals of the rheumatic diseases 1981;40(2):142-53.
1981: David Scott; G V Bradby; T J Aitman; G C Zaphiropoulos; C F Hawkins
Relationship of gold and penicillamine therapy to diffuse interstitial lung disease.
Annals of the rheumatic diseases 1981;40(2):136-41.
1981: J Wiggins; David Scott
Hepatic injury following feprazone therapy.
Rheumatology and rehabilitation 1981;20(1):44-5.
1981: G R Struthers; David Scott; J P Delamere; H Sheppeard; M Kitt
Smoking and rheumatoid vasculitis.
Rheumatology international 1981;1(3):145-6.
1981: David Scott; P A Bedford; K W Walton
The preparation of plasma fibronectin antigen and antiserum.
Journal of immunological methods 1981;43(1):29-33.
1980: David Scott; A H Smith; C J Eastmond; C J Hayter; V Wright
An evaluation of the techniques of sacro-iliac scintiscanning.
Rheumatology and rehabilitation 1980;19(2):76-82.
1979: David Scott; C J Eastmond; V Wright
A comparative radiological study of the pubic symphysis in rheumatic disorders.
Annals of the rheumatic diseases 1979;38(6):529-34.
1979: David Scott; H Bird; V Wright
Joint laxity leading to osteoarthrosis.
Rheumatology and rehabilitation 1979;18(3):167-9.
1979: C J Schorah; A Newill; David Scott; D B Morgan
Clinical effects of vitamin C in elderly inpatients with low blood-vitamin-C levels.
Lancet 1979;1(8113):403-5.